Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate XR (SPN-538) for migraine prevention in children 6-11 years
NCT04050293Phase 4Terminated
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Start
- Jul 2020
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of topiramate in migraine, sponsored by Supernus Pharmaceuticals, Inc.. Started Jul 2020; status: terminated.
02
Drugs
topiramate
03
Conditions
migraine
Beyond the preview
Go deeper on NCT04050293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04050293.